ClinicalTrials.Veeva

Menu

Retrospective Chart Review of the 5 & 2 & 2 and 4 & 2 & 1 Plans

M

Medifast

Status

Completed

Conditions

Obesity

Treatments

Other: 5 & 2 & 2 Plan
Other: 4 & 2 & 1 Plan

Study type

Observational

Funder types

Industry

Identifiers

NCT02150837
MED 017

Details and patient eligibility

About

The purpose of this study is to retrospectively and systematically review records of overweight and obese Medifast Weight Control Center (MWCC) members who have been assigned to the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan for weight loss to gain a better understanding of the effectiveness of these programs. The study will describe demographics of this population, along with weight loss, anthropometrics, body composition and effects on available cardiovascular parameters. Adherence to the plans will also be examined.

The study hypothesis is that the 5 & 2 & 2 Meal Replacement Plan and the 4 & 2 & 1 Meal Replacement Plan are both effective programs for weight loss in overweight and obese adults.

Enrollment

372 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult males and females, 18 years of age or older at the start of the weight loss program.
  • Subject has a BMI ≥ 25 kg/m2.
  • Subject started a weight management program at the MWCC location on or after January 1, 2012.
  • Subject followed the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan for at least the first two weeks of their weight loss phase while an active member of the MWCC.
  • Subject signed the Personal Health Information Consent Form.

Exclusion criteria

  • Subject was concurrently following another weight loss program other than the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan while on that respective plan.
  • Subject had documented use of prescription or over-the-counter weight loss pharmacotherapy (e.g., phentermine, Orlistat) concurrently with the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan.
  • Subject completed initial consultation but did not participate in any follow-up visits.
  • Subject is currently in the active weight loss phase of their program at the MWCC (Subjects in the transition or weight maintenance phases of their programs are eligible.)
  • Written request by subject to revoke consent to use health information is present in subject chart.

Trial design

372 participants in 2 patient groups

5 & 2 & 2 Plan
Description:
MWCC members who used the Medifast 5 \& 2 \& 2 Meal Replacement Plan for weight loss.
Treatment:
Other: 5 & 2 & 2 Plan
4 & 2 & 1 Plan
Description:
MWCC members who used the Medifast 4 \& 2 \& 1 Meal Replacement Plan for weight loss.
Treatment:
Other: 4 & 2 & 1 Plan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems